Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sungwoo Chemical is a South Korean pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and fine chemical intermediates. Established in 1977, the company has built a robust reputation as a reliable supplier of high-quality chemical components for the global and domestic pharmaceutical industries. Operating out of a GMP-certified facility in the Hyangnam Pharmaceutical Industrial Complex, Sungwoo Chemical produces a diverse range of APIs, including treatments for respiratory, gastrointestinal, and cardiovascular conditions. Their core competencies lie in advanced chemical synthesis and the production of complex small molecules such as levodropropizine and sarpogrelate. The company serves as a critical partner for pharmaceutical manufacturers, providing both off-the-shelf APIs and custom synthesis services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sungwoo Chemical.